HIGHLIGHTS
- who: Chio Okuyama from the Division of PET Imaging, Shiga Medical Center Research Institute, u20114u201130, Moriyamau2011cho, Moriyama City, Shiga, u20118524, Japan have published the Article: FDG-PET findings associated with various medical procedures and treatments, in the Journal: (JOURNAL)
SUMMARY
Fluorine-18 fluorodeoxyglucose (FDG) positron emission tomography (PET) or PET/computed tomography (PET/ CT) is a clinically accepted modality with high sensitivity for detecting malignant neoplastic lesions. Increased glucose metabolism with FDG accumulation is not only specific for neoplastic lesions but is also observed in many non-tumorous sites. Control of blood glucose . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.